Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma

International Journal of Oncology

Volumn 13, Issue 2, 1998, Pages 249-254

  Chen, Yi Jen ^a   Shih, Li Sun ^b   Chen, Yi Ming A ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b JEN AI HOSPITAL   (Taiwan)

Author keywords

Gastric carcinomas; p16; p53; Retinoblastoma

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; MESSENGER RNA; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

EID: 0031871170     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.2.249     Document Type: Article

References (24)

1. Meltlin C: Epidemiologic studies in gastric adenocarcinoma. In: Gastric Cancer. Douglass HO (ed). Churchill-Livingstone, New York, pp1-25, 1988.
2. Correa P: A human model of gastric carcinogenesis. Cancer Res 48: 3554-3560, 1988.
3. Lauren P: The two histological main types of gastric carcinoma diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 64: 31-49, 1965.
4. Ming SC: Gastric carcinoma, a pathobiological classification. Cancer 39: 2475-2485, 1977.
5. Tahara E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119: 265-272, 1993.
6. Bishop JM: Molecular themes in oncogenesis. Cell 64: 235-248, 1991.
7. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
8. Weinberg RA: Tumor suppressor genes. Science 254: 1138-1146, 1991.
9. White E: p53, guardian of Rb. Nature 371: 21-22, 1994.
10. Yokota J, Wada M, Shimosato Y and Sugimura T: Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and chromosome 3 in adeno-carcinoma of the lung. Proc Natl Acad Sci USA 84: 9252-9256, 1987.
11. Stratton MR, Moss S, Warren W, et al: Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene 5: 1297-1301, 1990.
12. Murakami Y, Hayashi K, Hirohashi S and Sekiya T: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51: 5520-5525, 1991.
13. Huang Y, Meltzer SJ, Yin J, et al: Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res 53: 1889-1894, 1993.
14. Pan H and Griep AE: Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev 8: 1285-1299, 1994.
15. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993.
16. Kamb A, Gruis NA, Weaver FJ, et al: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994.
17. Nobori T, Miura K, Wu DJ, et al: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756, 1994.
18. Mori T, Miura K, Aoki T, et al: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397, 1994.
19. Caldas C, Hahn SA, da Costa LT, et al: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8: 27-32, 1994.
20. Nagai H, Kinoshita T, Imamura J, et al: Genetic alteration of p53 in some patients with adult T-cell leukemia. Jpn J Cancer Res 82: 1421-1427, 1991.
21. Lin SF, Liu TC, Chen TP, et al: Diagnosis of thalassaemia by non-isotope detection of mRNA ratios. Br J Hematol 87: 133-138, 1994.
22. INK4 expression in primary lung cancers and cell lines. Cancer Res 55: 505-509, 1995.
23. Tam SW, Shay JW and Pagano M: Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16. Cancer Res 54: 5816-5820, 1994.
24. Hurlimann J and Saraga EP: Expression of p53 protein in gastric carcinomas, association with histologic type and prognosis. Am J Surg Pathol 18: 1247-1253, 1994.